Project coordinated by Cannect, with participation of a researcher from HC of USP and Santa Casa de São Paulo, gathers data from 2,500 patients to expand evidence on the impacts of medicinal cannabis on human health

Selected by SUPERA Park, Canabinote aims to mitigate medical uncertainty with technology based on scientific evidence and commercial neutrality

Research conducted on mice at the Ribeirão Preto School of Dentistry showed that the substance had a selective antipyretic effect

Clinical research suggests improvement in pain perception and emotional symptoms

Research from USP reveals how cannabis and antipsychotics affect patients with schizophrenia, pointing to new therapeutic pathways

Study by USP and Fiocruz shows that cannabidiol may reverse symptoms associated with autism in an animal model, paving the way for new treatments of ASD

Research from USP with an animal model reveals that cannabidiol (CBD) can simultaneously alleviate neuropathic pain and symptoms of depression, showing itself as a promising therapeutic alternative to traditional medications

USP specialist explains how cannabis use in adolescence can affect the development of the prefrontal cortex and warns about long-term cognitive and emotional impacts

Research suggests that the substance may stimulate tooth mineralization and reduce inflammation, paving the way for new dental treatments

International scientific study points out that four professors from the Faculty of Medicine of Ribeirão Preto are among the top ten producers of studies in the area